Introduction
Acetazolamide, with the National Drug Code (NDC) 70710-1591, is a medication manufactured and distributed by Zydus Pharmaceuticals USA Inc. This drug is used to treat various conditions, including glaucoma, epilepsy, and altitude sickness. Here, we will delve into the market analysis and price projections for this specific NDC.
Market Overview
Pharmaceutical Industry Trends
The pharmaceutical industry is undergoing significant transformations, driven by advancements in technology, regulatory shifts, and evolving market dynamics. Trends such as the continued dominance of small molecule drugs, increasing adoption of biologics, and the growing demand for personalized medicine are shaping the industry[3].
Drug Specifics
Acetazolamide
Acetazolamide is a carbonic anhydrase inhibitor that has been widely used for several decades. It is available in various formulations, including tablets, capsules, and injectable solutions. The NDC 70710-1591 specifically refers to the tablet form of acetazolamide manufactured by Zydus Pharmaceuticals USA Inc.[1].
Market Analysis
Competitive Landscape
The market for acetazolamide is relatively stable, with multiple generic versions available. Zydus Pharmaceuticals USA Inc. is one of the several manufacturers of this drug. The presence of generics typically keeps prices competitive, as multiple manufacturers can produce and distribute the drug once the original patent expires.
Demand and Usage
Acetazolamide is used for a range of medical conditions, including glaucoma, epilepsy, and altitude sickness. The demand for this drug is consistent due to its established use in these areas. However, the demand can fluctuate based on the prevalence of these conditions and the availability of alternative treatments.
Price Projections
Generic Pricing Dynamics
Generic drugs like acetazolamide generally have lower prices compared to their branded counterparts. The prices of generic drugs can vary based on the manufacturer, market competition, and regulatory factors.
-
Current Pricing: As of the current date, the prices of acetazolamide tablets are relatively low due to the generic nature of the drug. For example, a 250mg tablet might cost anywhere from $0.10 to $0.50 per unit, depending on the quantity and the pharmacy.
-
Future Projections: Given the stable demand and the presence of multiple generic manufacturers, the prices of acetazolamide are expected to remain relatively stable. However, any significant changes in raw material costs, manufacturing processes, or regulatory requirements could impact pricing.
Regulatory Considerations
National Drug Code (NDC) and FDA Regulations
The NDC 70710-1591 is part of the FDA's NDC Directory, which ensures that each drug product is identified and reported using a unique, three-segment number. This system helps in tracking and validating drug information, including payments and reporting under the Open Payments system[2][5].
Market Forecast
Sales and Revenue
While specific sales and revenue data for NDC 70710-1591 are not publicly available, the overall market for acetazolamide is expected to remain stable. The sales of generic drugs are often influenced by the volume of prescriptions and the competitive landscape.
-
Volume of Prescriptions: The consistent demand for acetazolamide due to its use in treating various medical conditions ensures a steady volume of prescriptions.
-
Competitive Landscape: The presence of multiple generic manufacturers keeps the market competitive, which can affect pricing and market share.
Unmet Needs and Future Developments
Personalized Medicine and Technological Advancements
While acetazolamide is a well-established drug, the broader pharmaceutical industry is moving towards personalized medicine and advanced technologies. However, these trends are more relevant to newer and more complex drugs rather than established generics like acetazolamide[3].
Key Takeaways
- Stable Demand: Acetazolamide has a consistent demand due to its established use in treating glaucoma, epilepsy, and altitude sickness.
- Competitive Pricing: The presence of multiple generic manufacturers keeps the prices of acetazolamide competitive.
- Regulatory Compliance: The NDC system ensures that drug information is accurately tracked and validated.
- Future Stability: Prices are expected to remain relatively stable unless there are significant changes in raw material costs, manufacturing processes, or regulatory requirements.
FAQs
Q: What is the primary use of acetazolamide?
A: Acetazolamide is primarily used to treat conditions such as glaucoma, epilepsy, and altitude sickness.
Q: Who manufactures the NDC 70710-1591?
A: The NDC 70710-1591 is manufactured by Zydus Pharmaceuticals USA Inc.
Q: How does the NDC system work?
A: The NDC system assigns a unique 10-digit code to each drug product, identifying the labeler, product, and trade package size.
Q: What are the key factors influencing the price of acetazolamide?
A: The price of acetazolamide is influenced by market competition, raw material costs, and regulatory factors.
Q: Is acetazolamide a branded or generic drug?
A: Acetazolamide is a generic drug, which typically results in lower prices compared to branded drugs.
Sources
- Find-A-Code: Zydus Pharmaceuticals USA Inc. - List of Drugs
- CMS: Drug Name and National Drug Code (NDC) Reference Data Instructions
- Global Pharma Tek: Top 12 Pharmaceutical Industry Trends in 2024
- Drug-Dev: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025
- FDA: National Drug Code Database Background Information
